← SynDRA
ML-246
SynDRA canonical compound SYN0040059 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | EEF1A2 |
|---|
| Mechanism of action | rna polymerase inhibitor |
|---|
| Indication | pancreatic cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADRA1A
- ADRA1B
- HTR1B
- HTR1D
- HTR1E
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- HTR5A
- HTR6
- HTR7
- OPRD1
- OPRK1
- OPRM1
- SIGMAR1
- SLC6A2
- SLC6A3
- SLC6A4
- HTR1A
- HRH2
- HRH1
- CHRM1
- ADRA1D
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- ADRB3
- CHRM2
- DRD5
- CHRM3
- CHRM4
- CHRM5
- DRD1
- DRD2
- DRD3
- DRD4
- TMEM97
Cross-references
Synonyms
Look up ML-246 in the interactive SynDRA portal →